The human cytomegalovirus protein, US11, initiates the destruction of MHC class I heavy chains by targeting them for dislocation from the ER to the cytosol and subsequent degradation by the proteasome. We report the development of a permeabilized cell system that recapitulates US11-dependent degradation of class I heavy chains. We have used this system, in combination with experiments in intact cells, to identify and order intermediates in the US11-dependent degradation pathway. We find that heavy chains are ubiquitinated before they are degraded. Ubiquitination of the cytosolic tail of heavy chain is not required for its dislocation and degradation, suggesting that ubiquitination occurs after at least part of the heavy chain has been dislocated from the ER. Thus, ubiquitination of the heavy chain does not appear to be the signal to start dislocation. Ubiquitinated heavy chains are associated with membrane fractions, suggesting that ubiquitination occurs while the heavy chain is still bound to the ER membrane. Our results support a model in which US11 co-opts the quality control process by which the cell destroys misfolded ER proteins in order to specifically degrade MHC class I heavy chains.
Skip Nav Destination
Article navigation
4 October 1999
Article|
October 04 1999
The Pathway of Us11-Dependent Degradation of Mhc Class I Heavy Chains Involves a Ubiquitin-Conjugated Intermediate
Caroline E. Shamu,
Caroline E. Shamu
aDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Craig M. Story,
Craig M. Story
bDepartment of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Tom A. Rapoport,
Tom A. Rapoport
aDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115
cHoward Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Hidde L. Ploegh
Hidde L. Ploegh
bDepartment of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Search for other works by this author on:
Caroline E. Shamu
aDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115
Craig M. Story
bDepartment of Pathology, Harvard Medical School, Boston, Massachusetts 02115
Tom A. Rapoport
aDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115
cHoward Hughes Medical Institute, Harvard Medical School, Boston, Massachusetts 02115
Hidde L. Ploegh
bDepartment of Pathology, Harvard Medical School, Boston, Massachusetts 02115
1.used in this paper: β2m, β2 microglobulin; Endo H, endoglycosidase H; HA, hemagglutinin; HCMV, human cytomegalovirus; HC, MHC class I heavy chain; IEF, isoelectric focusing; Staph A, fixed Staphylococcus aureus bacteria; TfR, transferrin receptor; Ub, ubiquitin; wt, wild-type; ZL3VS, carboxybenzyl-leucyl-leucyl-leucine vinyl sulfone
C.M. Story's present address is Syntonix Pharmaceuticals Inc., Woburn, MA 01801.
Received:
July 22 1999
Revision Requested:
August 24 1999
Accepted:
August 25 1999
Online ISSN: 1540-8140
Print ISSN: 0021-9525
© 1999 The Rockefeller University Press
1999
The Rockefeller University Press
J Cell Biol (1999) 147 (1): 45–58.
Article history
Received:
July 22 1999
Revision Requested:
August 24 1999
Accepted:
August 25 1999
Citation
Caroline E. Shamu, Craig M. Story, Tom A. Rapoport, Hidde L. Ploegh; The Pathway of Us11-Dependent Degradation of Mhc Class I Heavy Chains Involves a Ubiquitin-Conjugated Intermediate. J Cell Biol 4 October 1999; 147 (1): 45–58. doi: https://doi.org/10.1083/jcb.147.1.45
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement